SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Company: Alzheimer's Disease Ion Channel Modulator Companies

company 1,369 words KG: ent-dise-f9f64152 2026-03-28

kind:company section:companies state:published

Contents

Alzheimer's Disease Ion Channel Modulator Companies

Knowledge Graph

Related Hypotheses (23)

Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66 Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52

GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52 SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.51 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli
Score: 0.46 Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.44 HSP90-Tau Disaggregation Complex Enhancement
Score: 0.44 LRP1-Dependent Tau Uptake Disruption
Score: 0.44 Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.43 VCP-Mediated Autophagy Enhancement
Score: 0.41 Extracellular Vesicle Biogenesis Modulation
Score: 0.34 Synaptic Vesicle Tau Capture Inhibition
Score: 0.34 Trans-Synaptic Adhesion Molecule Modulation
Score: 0.34 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 Mechanosensitive Ion Channel Reprogramming
Score: 0.51 Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.49 Lysosomal Calcium Channel Modulation Therapy
Score: 0.49 Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.44

Related Analyses (20)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived

Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.95 CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90 s:** - Test whether HCN1 knockout specifically in EC layer I
falsification · proposed · Score: 0.40 Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40 AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40 Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.40 Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?
clinical · proposed · Score: 0.40 Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Anti-Tau Immunotherapy Dosing Optimization
clinical · proposed · Score: 0.40 ApoE4 Function in Alzheimer's Disease
validation · proposed · Score: 0.40 Experiment: Autoimmune Hypothesis Testing in AD
clinical · proposed · Score: 0.40 Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40 Biomarker-Guided Sequential Therapy Selection in Alzheimer's
clinical · proposed · Score: 0.40 Blood-Based Biomarker Panel for Early AD Detection
clinical · proposed · Score: 0.40 tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.40 Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.40 Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated
clinical · proposed · Score: 0.40 Cognitive Reserve Mechanisms in Alzheimer's Disease — Molecu
clinical · proposed · Score: 0.40 Cholinergic System Dysfunction in DLB — Mechanisms and Thera
clinical · proposed · Score: 0.40 Down Syndrome Alzheimer's Disease: Mechanisms and Therapeuti
clinical · proposed · Score: 0.40 Epigenetic Regulation Dysfunction in Alzheimer's and Parkins
clinical · proposed · Score: 0.40 FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40 Gap Junction Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Lifestyle Intervention Mechanisms in Alzheimer's Disease
validation · proposed · Score: 0.40 Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.40 Microbiome-Gut-Brain Axis in Alzheimer's Disease — mechanism
clinical · proposed · Score: 0.40 Microglial Aging and Immune Memory in Neurodegeneration — Tr
validation · proposed · Score: 0.40

See Also (15)

Vascular Dementia Mechanisms — Overlap with Alzheimer's
mechanism · Pages share 18 hypotheses Ubiquitin-Proteasome System Dysfunction in Alzheimer's
mechanism · Pages share 18 hypotheses Tau Kinase Signaling Cascade in Alzheimer's Disease
mechanism · Pages share 18 hypotheses Tau Kinase-Phosphatase Balance in Alzheimer's Disease
mechanism · Pages share 18 hypotheses Synaptic Loss in Alzheimer's Disease Pathway
mechanism · Pages share 18 hypotheses

Sporadic Alzheimer's Disease Pathway
mechanism · Pages share 18 hypotheses Sleep and Circadian Dysfunction in Alzheimer's Disease
mechanism · Pages share 18 hypotheses Sex-Specific Mechanisms in Alzheimer's Disease
mechanism · Pages share 18 hypotheses NLRP3 Inflammasome Pathway in Alzheimer's Disease
mechanism · Pages share 18 hypotheses Neurovascular Dysfunction in Alzheimer's Disease: Integ
mechanism · Pages share 18 hypotheses Neuroinflammation Hypothesis in Alzheimer's Disease
mechanism · Pages share 18 hypotheses Neuroinflammation in Alzheimer's Disease
mechanism · Pages share 18 hypotheses Mitochondrial Dysfunction in Alzheimer's Disease Pathwa
mechanism · Pages share 18 hypotheses Metal Ion Homeostasis in Alzheimer's Disease
mechanism · Pages share 18 hypotheses Locus Coeruleus Degeneration in Alzheimer's Disease
mechanism · Pages share 18 hypotheses

SciDEX — scidex.ai — Dashboard | Atlas